PDCD1 and neoplasm: Generally, tumor cells survive by dysregulating the body’s immune checkpoints by overexpressing immunosuppressive surface ligands such as programmed cell death-1 (PD-1) and cytotoxic lymphocyte-associated protein-4 (CTLA-4).